Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Pfizer Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199229-06-2012
29-06-2012
Outcome of Board Meeting
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 28, 2012, has accepted the resignation of Mr. Kewal Handa as the Director and Managing Director of the Company with effect from the end of day on August 15, 2012, Mr. Kewal Handa would continue as an employee of the Company until his retirement from the Company i.e. August 31, 2012....28-06-2012
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Pfizer Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199223-05-2012
Revised Financial Results for March 31, 2012
Pfizer Ltd has informed BSE about the Revised Financial Results for the period ended March 31, 2012.21-05-2012
Resignation of Director
Pfizer Ltd has informed BSE that Dr. Bomi M. Gagrat, Non-Executive Director has resigned from the Board of Directors of the Company with effect from the close of business hours on May 21, 2012.21-05-2012
Outcome of Board Meeting
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 21, 2012 appointed the following Additional Directors on the board of the Company with effect from May 21, 2012:1. Mr. Uday Khanna.2. Mr. Sunil Madhok, designated as Executive Director, Business Operations.3. Mr. Vivek Dhariwal, designated as Executive Director, Technical Operations....21-05-2012
Board recommends Dividend
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 21, 2012, inter alia, recommended a dividend of Rs. 12.50/- per Equity share of Rs. 10 each (125%) for the year ended March 31, 2012. The said dividend, if declared at the ensuing Annual General Meeting of the Company, shall be paid on August 16, 2012.21-05-2012
Financial Results & Auditors Report for March 31, 2012
Pfizer Ltd has informed BSE about the Financial Results & a copy of the Auditors Report for the period ended March 31, 2012.21-05-2012
Board to consider Dividend
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 21, 2012, inter alia, to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2012 and to recommend dividend thereon.10-05-2012